progeria

New research shows that CRISPR base editing can reduce vascular defects linked to progeria, the rare genetic syndrome that causes accelerated aging in children. By correcting the underlying mutation effects in blood vessels, the approach offers a potential treatment path for the currently incurable disease. The findings are drawing attention in the gene-editing and rare-disease research communities.